emerg
evid
indic
diminish
activ
vasoprotect
axi
reninangiotensin
system
constitut
angiotensinconvert
enzym
enzymat
product
angiotensin
ang
contribut
pathogenesi
pulmonari
hypertens
ph
howev
longterm
repetit
deliveri
ang
would
requir
enhanc
protein
stabil
eas
administr
improv
patient
complianc
chloroplast
express
therapeut
protein
enabl
bioencapsul
within
plant
cell
protect
gastric
enzymat
degrad
facilit
longterm
storag
room
temperatur
besid
fusion
transmucos
carrier
help
effect
system
absorpt
intestin
oral
deliveri
hypothes
bioencapsul
ang
fuse
cholera
nontoxin
b
subunit
would
enabl
develop
oral
deliveri
system
effect
treat
ph
ph
induc
male
spragu
dawley
rat
monocrotalin
administr
subset
anim
simultan
treat
bioencapsula
ang
prevent
protocol
separ
set
experi
drug
treatment
initi
week
ph
induct
revers
protocol
oral
feed
rat
bioencapsul
ang
prevent
develop
monocrotalineinduc
ph
improv
associ
cardiopulmonari
pathophysiolog
furthermor
revers
protocol
oral
ang
treatment
significantli
arrest
diseas
progress
along
improv
right
heart
function
decreas
pulmonari
vessel
wall
thick
addit
combin
therapi
ang
augment
benefici
effect
monocrotalineinduc
lung
injuri
studi
provid
proofofconcept
novel
lowcost
oral
ang
deliveri
system
use
transplastom
technolog
pulmonari
diseas
therapeut
keyword
chloroplast
molecular
farm
plantmad
pharmaceut
pulmonari
hypertens
reninangiotensin
system
pulmonari
hypertens
ph
devast
lung
diseas
character
elev
blood
pressur
pulmonari
circul
eventu
lead
right
heart
failur
death
although
signific
advanc
made
recent
year
improv
qualiti
life
patient
ph
none
current
treatment
success
revers
ph
decreas
mortal
led
realiz
novel
mechanismbas
therapi
must
develop
accomplish
goal
wellrecogn
activ
vasodeleteri
axi
reninangiotensin
system
ra
compris
angiotensinconvert
enzym
ace
angiotensin
ii
angiotensin
type
receptor
involv
develop
ph
howev
clinic
use
ace
inhibitor
blocker
yield
mix
result
therebi
fail
reach
consensu
opinion
use
ph
therapi
nonetheless
recent
discoveri
close
homolog
ace
result
reevalu
role
ra
ph
wide
express
lung
predominantli
pulmonari
vascular
endothelium
catalyz
convers
angiotensin
ii
angiotensin
ang
ang
vasoact
heptapeptid
mediat
effect
stimul
ma
receptor
thu
ma
receptor
constitut
vasoprotect
axi
ra
counterbal
deleteri
action
aceangiotensin
axi
recent
report
indic
decreas
tissu
circul
level
associ
lung
diseas
human
howev
restor
genet
overexpress
administr
recombin
protein
use
pharmacolog
activ
result
cardiopulmonari
protect
effect
anim
model
pulmonari
diseas
find
provid
compel
evid
initi
clinic
trial
recombin
ang
treat
pulmonari
disord
although
clinic
trial
current
underway
cost
manufactur
protein
stabil
repetit
intraven
dose
patient
complianc
pose
major
impedi
realiz
full
therapeut
potenti
therapi
think
develop
plantbas
oral
deliveri
system
ideal
approach
overcom
aforement
challeng
achiev
clinic
success
therefor
object
studi
develop
lowcost
oral
deliveri
system
administ
ang
test
efficaci
experiment
model
ph
took
advantag
transplastom
technolog
enabl
chloroplast
gener
high
level
therapeut
protein
within
plant
leav
technolog
present
minim
risk
human
pathogen
endotoxin
contamin
elimin
complex
protein
purif
step
abolish
cold
chain
steril
deliveri
requir
commonli
associ
protein
therapi
efficaci
plantbas
pharmaceut
valid
fact
food
drug
administr
recent
approv
use
taligluceras
alfa
trade
name
elelyso
treatment
gaucher
diseas
studi
provid
evid
develop
oral
deliveri
system
administ
ang
use
transplastom
technolog
demonstr
efficaci
establish
rat
model
monocrotalineinduc
ph
onlineonli
data
supplement
includ
detail
descript
method
addit
support
data
nativ
human
cdna
synthet
ang
dna
sequenc
clone
chloroplast
transform
vector
pldutr
figur
effici
deliveri
protein
circul
carrier
protein
cholera
nontox
b
subunit
ctb
fuse
n
termin
therapeut
protein
figur
facilit
transmucos
deliveri
bind
monosialotetrahexosylgangliosid
receptor
present
intestin
epitheli
cell
hing
glyproglypro
furin
cleavag
site
argarglysarg
place
ctb
therapeut
protein
figur
elimin
steric
hindranc
aid
system
releas
therapeut
protein
intern
via
ligandreceptor
complex
format
surfac
epitheli
cell
express
fusion
gene
driven
light
regul
strong
chloroplast
psba
promot
transcript
stabil
place
psba
untransl
region
end
fusion
gene
figur
select
chloroplast
transform
fusion
gene
gene
aada
driven
chloroplast
ribosom
rna
promot
prrn
incorpor
express
cassett
confer
transform
resist
spectinomycin
figur
express
cassett
flank
dna
sequenc
isoleucyltrna
synthetas
trni
alanyltrna
synthetas
trna
gene
ident
nativ
chloroplast
genom
flank
figur
flank
sequenc
serv
facilit
transgen
integr
chloroplast
genom
figur
via
doubl
homolog
recombin
chloroplast
transform
vector
express
ang
gene
coat
onto
gold
particl
deliv
chloroplast
use
biolist
particl
deliveri
system
bombard
plant
leav
grown
spectinomycincontain
plant
regener
media
shoot
regener
media
investig
sitespecif
integr
transgen
chloroplast
genom
homoplasmi
transgen
absenc
untransform
genom
use
southern
blot
analysi
radioisotopelabel
probe
span
trni
trna
flank
sequenc
hindiiidigest
chloroplast
genom
dna
independ
transplastom
line
transplastom
line
show
hybrid
fragment
kb
intern
hind
iii
site
figur
fragment
kb
ctbang
confirm
absenc
untransform
chloroplast
genom
figur
thu
stabl
integr
transgen
confirm
homoplasm
line
use
studi
confirm
homoplasm
line
multipli
use
anoth
round
antibiot
select
asept
condit
cultiv
control
greenhous
increas
biomass
express
vari
total
leaf
protein
figur
depend
harvest
time
transgen
regul
light
via
chloroplast
psba
promot
similarli
express
level
ctbang
vari
total
leaf
protein
figur
differ
durat
illumin
reach
maximum
express
end
day
henc
perform
vivo
experiment
studi
therapeut
leaf
materi
harvest
pm
powder
liquid
nitrogen
therapeut
protein
fuse
transmucos
carrier
ctb
b
subunit
singl
intrasubunit
disulfid
bond
stabil
ctb
monom
monom
assembl
form
ringshap
pentamer
structur
via
intersubunit
interact
includ
hydrogen
bond
salt
bridg
hydrophob
interact
upon
oral
administr
pentamer
form
ctb
bind
gut
epitheli
receptor
intern
henc
investig
proper
format
pentamer
structur
ctbfuse
protein
bind
affin
receptor
use
bind
affin
ctb
pentam
receptor
measur
spectrophotometr
function
absorb
nm
therapeut
protein
fresh
leaf
materi
show
compar
absorb
ctb
figur
confirm
chloroplast
form
disulfid
bridg
fold
assembl
fusion
protein
also
lyophil
leav
express
ang
evalu
affin
receptor
figur
lyophil
maintain
proper
fold
disulfid
bond
pentam
assembl
also
facilit
longterm
storag
room
temperatur
figur
furthermor
western
blot
assay
perform
nonreduc
condit
without
dithiothreitol
boil
show
monomer
form
cleav
fragment
ctbang
figur
western
blot
imag
major
band
pentamer
assembl
ctb
detect
around
kda
figur
arrow
head
expect
band
pentamer
assembl
ctbang
detect
figur
arrow
therefor
result
confirm
therapeut
protein
express
chloroplast
exist
intact
pentamer
form
oral
gavag
frozen
powder
leav
mg
steril
phosphatebuff
salin
untransform
wild
type
ctbang
transplastom
plant
perform
twice
daili
week
monocrotalinechalleng
rat
monocrotalin
inject
caus
robust
elev
right
ventricular
systol
pressur
rvsp
figur
associ
develop
rv
hypertrophi
rvh
figur
contrast
monocrotalin
anim
gavag
either
ang
show
consider
reduct
rvsp
rvh
figur
furthermor
measur
hemodynam
paramet
monocrotalin
anim
reveal
increas
rv
enddiastol
pressur
dp
dt
convers
treatment
ang
restor
paramet
nearcontrol
level
figur
echocardiographi
monocrotalin
rat
reveal
increas
ratio
rv
left
ventricl
enddiastol
area
impli
dilat
right
heart
figur
figur
onlineonli
data
supplement
accompani
decreas
eject
fraction
ef
measur
ratio
rv
left
ventricl
ef
figur
figur
addit
puls
doppler
blood
flow
measur
reveal
decreas
flow
rate
rv
outflow
tract
figur
furthermor
video
echocardiographi
reveal
maladapt
structur
remodel
monocrotalin
rat
heart
compar
control
movi
si
sii
howev
oral
deliveri
ang
exhibit
improv
cardioprotect
effect
ang
effect
decreas
rv
dilat
figur
increas
ef
figur
prevent
monocrotalineinduc
decreas
rv
outflow
tract
blood
flow
figur
benefici
effect
associ
reduc
cardiac
remodel
evidenc
echocardiographi
video
movi
siii
siv
concurr
rv
fibrosi
pulmonari
vessel
wall
thick
also
decreas
figur
oral
feed
associ
increas
circul
activ
compar
monocrotalin
alon
rat
figur
increas
circul
level
ang
figur
interestingli
ang
alter
basal
system
blood
pressur
control
monocrotalin
monocrotalin
monocrotalineang
experiment
group
next
test
whether
oral
feed
ang
initi
ph
could
arrest
diseas
progress
observ
week
monocrotalin
challeng
induc
signific
elev
rvsp
mm
hg
compar
control
figur
henc
studi
oral
therapi
initi
week
monocrotalin
challeng
treatment
continu
addit
day
regim
treatment
ang
inhibit
elev
monocrotalineinduc
rvsp
rvh
figur
associ
increas
circul
level
ang
figur
improv
hemodynam
paramet
regard
lower
rv
enddiastol
pressur
decreas
dpdt
reduc
also
observ
figur
addit
therapi
decreas
rv
dilat
figur
figur
figur
increas
rvef
figur
figur
support
echocardiographi
video
movi
sv
svi
subsequ
blood
flow
rv
outflow
tract
also
improv
figur
final
rv
fibrosi
pulmonari
vessel
wall
thicken
significantli
attenu
treat
anim
figur
next
evalu
effect
combin
therapi
ang
wherein
mg
mg
ang
plant
materi
combin
revers
protocol
follow
studi
wherein
combin
therapi
initi
week
monocrotalin
challeng
treatment
continu
next
day
expect
observ
better
protect
effect
mg
combin
combin
show
reduct
rvsp
addit
decreas
rv
lv
ratio
compar
mg
combin
figur
similarli
enhanc
benefici
effect
mg
combin
observ
hemodynam
paramet
rv
enddiastol
pressur
dpdt
figur
dose
combin
therapi
effect
decreas
rv
dilat
figur
figur
increas
ef
figur
figur
accompani
greater
rv
outflow
tract
blood
flow
figur
observ
support
echocardiographi
video
movi
vii
viii
consist
improv
rv
fibrosi
pulmonari
vessel
wall
thick
combin
therapi
figur
hypothes
oral
deliveri
ang
would
correct
ra
imbal
inhibit
proinflammatori
cytokin
data
figur
support
hypothesi
monocrotalin
rat
reveal
increas
pulmonari
mrna
level
ace
figur
result
increas
ratio
respect
figur
convers
mrna
level
increas
wherea
decreas
ang
fed
monocrotalin
rat
result
decreas
ratio
furthermor
monocrotalinechalleng
anim
show
increas
mrna
level
tumor
necrosi
transform
growth
tolllik
markedli
reduc
ang
treatment
figur
recent
report
indic
autophag
protein
degrad
pathway
activ
monocrotalinechalleng
anim
accordingli
observ
lung
protein
autophagi
marker
significantli
increas
monocrotalinechalleng
rat
figur
howev
ang
decreas
level
impli
inhibit
autophagi
similar
result
respect
ra
modul
antiinflammatori
properti
inhibit
autophagi
observ
revers
protocol
monotherapi
either
ang
combin
therapi
figur
signific
find
studi
develop
system
gener
human
ang
within
plant
chloroplast
use
transplastom
technolog
oral
administ
rat
attenu
ph
although
previou
genet
intervent
demonstr
benefici
effect
anim
sever
challeng
limit
clinic
develop
approach
incid
ph
increas
among
elderli
global
popul
necessit
afford
medic
mass
although
drug
made
plant
cell
approv
food
drug
administr
current
market
target
gene
therapi
still
experiment
stage
far
away
clinic
applic
even
gene
therapi
approv
valid
approach
would
still
access
global
popul
limit
expertis
avail
hospit
gene
therapi
contrast
oral
deliveri
plant
capsul
contain
therapeut
protein
feasibl
much
afford
drug
deliveri
import
drug
discoveri
studi
focus
develop
novel
lowcost
deliveri
system
administ
therapeut
protein
like
found
effect
experiment
model
lung
diseas
yet
clinic
approv
inject
deliveri
pose
uniqu
challeng
respect
cost
manufactur
protein
stabil
cold
storag
shelf
life
steril
deliveri
requir
health
professionalshospit
administr
concern
easili
elimin
oral
deliv
therapeut
protein
bioencapsul
plant
cell
current
produc
inject
protein
drug
afford
half
global
popul
despit
decad
optim
process
develop
develop
oral
deliveri
system
administ
ang
report
made
tremend
advanc
move
field
forward
take
toward
translationalclin
research
treatment
pulmonari
diseas
ang
express
plant
chloroplast
fusion
protein
ctb
although
ang
gene
product
synthet
gene
encod
ang
use
studi
chloroplast
ideal
bioreactor
produc
human
therapeut
protein
total
copi
number
transgen
per
cell
expect
result
hyperexpress
total
leaf
protein
singl
plant
cell
chloroplast
chloroplast
copi
chloroplast
genom
copi
transgen
transform
plant
cell
observ
copi
number
quantifi
quantit
polymeras
chain
reaction
previou
studi
howev
practic
way
literatur
evalu
homoplasmi
transform
chloroplast
genom
plant
cell
show
absenc
nativ
untransform
chloroplast
genom
shown
figur
moreov
system
allow
appropri
disulfid
bond
format
proper
protein
fold
assembl
also
bioencapsul
protein
within
plant
cell
protect
gastric
degrad
importantli
fuse
transmucos
carrier
ctb
therapeut
protein
effect
releas
system
circul
microb
colon
gut
lyse
plant
cell
interact
also
present
cell
membran
retina
nervou
system
henc
target
ctbfuse
therapeut
protein
report
recent
studi
chloroplast
capabl
produc
high
level
express
foreign
gene
howev
express
level
kda
expect
compar
ang
figur
prokaryot
natur
chloroplast
wellsuit
express
eukaryot
human
gene
bia
codon
prefer
usag
exampl
nativ
prokaryot
gene
bacillu
anthraci
bacillu
thuringiensi
express
total
solubl
protein
chloroplast
small
nativ
human
gene
insulin
like
growth
kda
proinsulin
kda
kda
express
chloroplast
high
level
howev
larger
human
nativ
gene
like
blood
clot
factor
express
chloroplast
lower
level
analysi
nucleotid
sequenc
observ
codon
rare
codon
would
readili
exhaust
correspond
trna
pool
leav
rel
abund
trna
unus
therefor
clinic
develop
codon
optim
express
edibl
system
lettuc
consid
use
ctb
transmucos
carrier
facilit
uptak
ang
circul
ctb
fusion
protein
disulfid
bond
form
pentam
properli
fold
observ
ctb
fusion
protein
ctb
approv
adjuv
use
sever
clinic
set
administr
ctbfuse
antigen
behcet
diseas
peptid
human
autoimmun
eye
disord
induc
immunolog
toler
suppress
abnorm
tcell
reactiv
peptid
also
immun
suppress
autoantigen
proinsulin
factor
ix
link
ctb
observ
anim
studi
oral
administr
likewis
studi
shown
immunesuppress
effect
ctb
fuse
autoimmun
allerg
caus
agent
receptor
present
intestin
epitheli
cell
make
ctb
appropri
carrier
transport
therapeut
protein
system
circul
receptor
wide
distribut
intestin
mucosa
rapid
turnov
rate
halflif
nativ
ang
short
howev
studi
stabil
ang
found
increas
sera
plant
cell
ctb
stabil
ang
format
pentam
figur
thu
confer
protect
plant
proteas
howev
monom
observ
sera
deliveri
sera
although
furin
cleavag
site
facilit
remov
ctb
effici
cleavag
depend
flank
amino
acid
sequenc
fuse
protein
ang
fuse
ctb
provid
optim
furin
cleavag
site
flank
furin
prefer
basic
amino
acid
ntermin
side
serinevalin
ctermin
side
therefor
anticip
furin
cleavag
rapid
effici
offer
greater
ntermin
protect
ang
extend
stabil
sever
hour
sera
compar
inject
ang
actual
continu
treatment
bioencapsul
ang
show
signific
increas
circul
level
peptid
figur
suggest
oral
gavag
twice
daili
bioencapsul
ang
result
sustain
elev
plasma
level
ang
treat
anim
ang
concentr
frozen
leaf
materi
found
translat
mg
dose
compar
well
previou
studi
wherein
ang
peptid
administ
rat
per
g
rat
oral
feed
bioencapsul
ang
prevent
develop
importantli
retard
progress
monocrotalineinduc
ph
upregul
deleteri
aceangiotensin
axi
downregul
protect
ma
axi
contribut
ph
pathogenesi
thu
maintain
equilibrium
axe
crucial
preserv
pulmonari
vascular
homeostasi
oral
deliveri
ang
increas
decreas
ratio
signifi
improv
pulmonari
ra
balanc
interest
note
serum
activ
monocrotalin
anim
decreas
compar
control
howev
affect
circul
level
ang
could
possibl
altern
endopeptidas
pathway
ang
gener
neprilysin
thimet
oligopeptidas
howev
oral
feed
prevent
decreas
serum
activ
monocrotalin
anim
associ
increas
circul
level
ang
figur
fact
fed
rat
exhibit
increas
enzymat
activ
compar
monocrotalin
alon
anim
importantli
increas
suffici
exert
benefici
effect
ph
pathophysiolog
previou
experiment
studi
shown
exogen
administr
recombin
increas
serum
activ
exert
therapeut
efficaci
sever
diseas
model
increas
serum
level
also
clinic
signific
abnorm
low
level
serum
associ
ph
surprisingli
pulmonari
mrna
level
increas
oral
feed
specul
increas
posit
feed
forward
mechan
similar
increas
report
previous
also
level
increas
treatment
consist
previou
studi
show
protect
role
receptor
cardiopulmonari
diseas
furthermor
favor
ra
modul
ang
associ
reduc
lung
inflammatori
cytokin
proinflammatori
cytokin
contribut
thicken
pulmonari
arteriol
lead
heighten
pulmonari
pressur
line
find
observ
mark
increas
vessel
wall
thick
monocrotalinechalleng
anim
howev
ang
treatment
significantli
inhibit
medial
wall
thick
observ
effect
could
attribut
reduct
proinflammatori
cytokin
well
direct
antiprolif
action
vascular
smooth
muscl
cell
content
support
earlier
studi
recent
studi
implic
autophagi
ph
observ
increas
autophagi
marker
monocrotalin
rat
significantli
decreas
ang
treatment
collect
aforement
find
suggest
oral
deliveri
ang
correct
dysregul
pulmonari
ra
reduc
inflamm
decreas
vascular
remodel
inhibit
autophagi
exert
lungprotect
effect
importantli
ang
treatment
lower
basal
system
blood
pressur
import
induct
system
hypotens
detriment
patient
ph
similar
phenomenon
also
observ
studi
wherein
chronic
administr
ang
fail
decreas
system
blood
pressur
varieti
model
hypertens
one
possibl
may
relat
pulmonari
vasculatur
sensit
ang
abund
receptor
ang
present
pulmonari
vessel
furthermor
combin
ang
treatment
produc
benefici
effect
cardiopulmonari
system
observ
higher
dose
combin
yield
better
effect
lower
dose
particular
interest
cardioprotect
effect
oral
therapi
sustain
pressur
overload
right
heart
induc
ventricular
remodel
dysfunct
echocardiographi
monocrotalin
rat
reveal
promin
structur
chang
heart
rv
assum
round
shape
shift
intraventricular
septum
caus
rv
dilat
reduc
ef
addit
pulmonari
arteri
flow
significantli
lower
monocrotalin
group
chang
associ
develop
rvh
increas
interstiti
fibrosi
cardiac
dysfunct
howev
ang
treatment
restor
normal
heart
structur
inhibit
rv
dilat
improv
ef
also
rvh
interstiti
fibrosi
significantli
reduc
along
preserv
cardiac
function
moreov
combin
therapi
ang
found
exert
superior
cardioprotect
effect
evid
implic
therapeut
potenti
axi
multipl
diseas
ph
lungfibrosi
heart
failur
renal
diseas
diabet
retinopathi
studi
provid
proofofconcept
lowcost
plantbas
oral
deliveri
system
ang
bioencapsul
plant
chloroplast
transplastom
technolog
offer
potenti
scaleup
gener
bulk
quantiti
therapeut
activ
ang
toward
undertak
translat
studi
simpl
oral
deliveri
system
direct
lyophil
leav
express
ang
concentr
therapeut
protein
respect
loss
bind
affin
receptor
figur
concentr
effect
packag
protein
per
milligram
lyophil
leav
result
elimin
water
dehydr
process
chang
percentag
total
leaf
protein
fresh
lyophil
plant
leav
freezedri
method
also
advantag
reduc
cost
associ
protein
purif
elimin
microbi
contamin
facilit
longterm
storag
therapeut
protein
capsul
room
temperatur
import
consider
clinic
develop
refer
web
version
pubm
central
supplementari
materi
new
studi
provid
evid
first
time
develop
lowcost
oral
deliveri
system
administr
angiotensinconvert
enzym
angiotensin
use
transplastom
technolog
provid
impress
protect
pulmonari
hypertens
relev
angiotensinconvert
enzym
angiotensin
tremend
therapeut
potenti
treat
pulmonari
hypertens
howev
cost
manufactur
protein
stabil
repetit
intraven
dose
patient
complianc
pose
major
impedi
success
clinic
therapi
develop
plantbas
oral
deliveri
system
overcom
challeng
realiz
full
therapeut
potenti
protein
oral
deliveri
angiotensinconvert
enzym
angiotensin
bioencapsul
plant
cell
provid
protect
pulmonari
hypertens
associ
cardiopulmonari
patholog
oral
feed
bioencapsul
angiotensinconvert
enzym
angiotensin
ang
exert
antifibrot
antiremodel
effect
prevent
protocol
interstiti
collagen
deposit
right
ventricl
b
stain
muscl
actin
quantifi
medial
wall
thick
pulmonari
arteri
measur
scale
bar
c
activ
measur
rat
sera
collect
differ
experiment
group
data
repres
mean
sem
p
vs
group
p
compar
control
wherea
repres
p
vs
untreat
wildtyp
wt
plant
materialf
monocrotalin
mct
rat
assess
anova
follow
newmankeul
test
afu
indic
arbitrari
fluoresc
unit
effect
angiotensinconvert
enzym
angiotensin
ang
treatment
lung
reninangiotensin
system
proinflammatori
cytokin
autophagi
prevent
protocol
rel
chang
lung
mrna
level
ace
b
c
ratio
angiotensin
type
receptor
e
angiotensin
type
receptor
f
receptor
rel
mrna
level
lung
proinflammatori
cytokin
g
tumor
necrosi
factor
tnf
h
transform
growth
factor
tgf
tolllik
monocrotalin
mct
studi
autophagi
marker
increas
lung
mctexpos
anim
j
immunoblot
densitometri
analysi
lung
protein
express
data
express
mean
sem
p
p
p
vs
control
rat
p
vs
mct
group
wt
indic
wild
type
effect
monotherapi
well
combin
therapi
lung
reninangiotensin
system
compon
proinflammatori
cytokin
autophagi
revers
protocol
data
repres
rel
chang
lung
mrna
level
angiotensinconvert
enzym
ace
b
c
ace
ratio
angiotensin
type
receptor
e
angiotensin
type
receptor
f
ratio
rel
mrna
level
lung
proinflammatori
cytokin
g
tumor
necrosi
factor
tnf
h
transform
growth
factor
tgf
tolllik
studi
j
immunoblot
densitometri
quantif
show
lung
protein
express
data
express
mean
sem
p
p
vs
control
rat
wherea
p
vs
monocrotalin
mct
group
wt
indic
wild
type
